Critically, combining the genetically and epigenetically engineered mouse models revealed that p16 epimutation exacerbates the intestinal tumorigenesis initiated by Apc mutation, thus directly linking CRC development and progression to an epigenetic aging marker. Here, CDKN2A is linked to colorectal carcinoma.